Until now, the business rationale has been undermined by the sheer amount of labor needed to validate and bring intelligent automation systems up to full functionality for life sciences R&D purposes, such as transforming adverse event (AE) reporting. These obstacles are now being removed, and compliance is being strengthened by the LLMs (large language models)